References
- R. Wang, (2004) Signal transduction and the gasotransmitters: NO, CO,
and H2S in biology and medicine, Humana, Totowa
(2004).
- P. K.Allan and R. E. Morris, Medical Applications of Solid Nitrosyl
Complexes, in “Nitrosyl Complexes in Inorganic Chemistry,
Biochemistry and Medicine II, D. M. P. Mingos (Ed.), 154 Structure and
Bonding, Springer, Springer-Verlag Berlin Heidelberg (2014).
- L. J. Ignarro, Endothelium-derived nitric oxide: Pharmacology and
relationship to the actions of organic nitrate esters,Pharmacol. Res. , 6, 651–659, 1989.
- L. J. Ignarro, G. M. Buga, K.S. Wood, R. E. Byrns and G. Chaudhuri,
Endothelium-derived relaxing factor produced and released from artery
and vein is nitric oxide, Proc. Natl. Acad. Sci. U.S.A. , 84,
9265–9269, 1987.
- D. E. Koshland, The molecule of the year, Science, 258(1992) 1861; J.
S. Stamler, D. J. Singel and J. Loscalzo, Biochemistry of nitric oxide
and its redox-activated forms, Science , 258(1992) 1898-1902.
- L. J. Ignarro, Ed., Nitric Oxide: Biology and Pathobiology, Academic
Press, San Diego (2000).
- A. R. Butler and R. Nicholson, Life, Death and Nitric Oxide, The Royal
Society of Chemistry, Cambridge, UK (2003).
- S. Kalsner, Ed., Nitric Oxide and Free radicals in Peripheral
Neurotransmission, Birkhauser, Boston, MA (2000).
- S. R. Vincent, Nitric oxide neurons and neurotransmission.Progress in Neurobiology , 90(2010) 246-255.
- F. C. Fang, Ed., Nitric Oxide and Infection, Kluwer Academic/Plenum
Publishers: New York (1999).
- S. Moncada, E. A. Higgs and G. Bagetta, Eds., Nitric Oxide and Cell
Proliferation, Differentiation and Death, Portland Press, London
(1998).
- A. J. Burke, F. J. Sullivan, F. J. Giles and S. A. Glynn,
The yin
and yang of nitric oxide in cancer progression,Carcinogenesis , 34 (2013) 503-512.
- J. O. Lundberg, E. Weitzberg , J. A. Cole, N. Benjamin, Nitrate,
bacteria and human health, Nat. Rev. Microbiol ., 2 (2004)
593-602.
- L. A. H. Bowman, S. McLean, R. K. Poole, J. Fukuto, The diversity of
microbial responses to nitric oxide and agents of nitrosative stress
close cousins but not identical twins,Advances in Microbial
Physiology , 59 (2011) 135-219.
- F. C. Fang, Antimicrobial reactive oxygen and nitrogen species:
Concepts and controversies,Nat. Rev. Microbiol. , 2 (2004)
820-832.
- G. M. King and C. F. Weber, Distribution, diversity and ecology of
aerobic CO-oxidizing bacteria,Nat. Rev. Microbiol ., 5(2007)
107-118.
- R. C. Maurya and J. M. Mir, Medicinal industrial and environmental
relevance of metal nitrosyl complexes: A review,Int. J. Sci.
Eng. Res ., 5 (2014) 305-320.
- L. Wu and R. Wang, Carbon monoxide: endogenous production,
physiological functions, and pharmacological applications,Pharmacological Reviews , 57 (2005) 585-630.
- C. G. Douglas, J. S. Haldane and J. B. Haldane, The laws of
combination of haemoglobin with carbon monoxide and oxygen, The
Journal of Physiology , 44 (1912) 275-304; J. B. S. Haldane, Carbon
monoxide as a tissue poison, Biochemical Journal , 21 (1927)
1068-1075.
- L. K. Weaver, Carbon monoxide poisoning, Crit. Care Clin ., 15
(1999) 297-317; D. Gorman, A. Drewry, Y. L. Huang and C. Sames, The
clinical toxicology of carbon monoxide, Toxicology , 187 (2003)
25-38.
- T. Sjostrand, Early studies of CO production, Ann. NY Acad.
Sci ., 174 (1970) 5−10.
- A. Verma, D. J. Hirsch, C. E. Glatt, G. V. Ronnett and S. H. Snyder,
Carbon monoxide: a putative neural messanger, Science , 259
(1993) 381−384.
- P. A. Rodgers, H. J. Vreman, P. A. Dennery and D. K. Stevenson, D. K.,
Sources of carbon monoxide (CO) in biological systems and applications
of CO detection technologies, Semin Perinatol ,18 (1994) 2−10.
- H. Yuyi, S. Qianwen, Y. Jin and J. Yong, Hydrogen sulfide: a gaseous
signaling molecule modulates tissue homeostasis: implications in
ophthalmic diseases, Cell Death and Disease (2019) 10 (2019)
293-304.
- R. Wang, 2002. Two’s company, three’s a crowd: can H2S
be the third endogenous gaseous transmitter?,FASEB J ., 16
(2002) 1792−1798.
- R. K. Olson, J. A. Donald, R. A. Dombkowski and S. F. Perry,
Evolutionary and comparative aspects of nitric oxide, carbon monoxide
and hydrogen sulfide, Respir. Physiol. Neurobiol ., 184 (2012)
117–129.
- M. M. Gadalla and S. H. Snyder, Hydrogen sulfide as a gasotransmitter,J. Neurochem ., 113(2010) 14–26.
- R. K. Olson, E. R. DeLeon and F. Liu, Controversies and conundrums in
hydrogen sulfide biology, Nitric Oxide , 41, 11–26 (2014); B.
Olas, Hydrogen sulfide in hemostasis: friend or foe?,Chem.-Biol.
Interact ., 217(2014) 49.
- R. K. Olson, Is hydrogen sulfide a circulating “gasotransmitter” in
vertebrate blood?,Biochim. Et. Biophys. ActaBioenerg ., 1787
(2009) 856–863.
- P. J. Hogg, Contribution of allosteric disulfide bonds to regulation
of hemostasis, J. Thromb. Haemost ., 7 (2009) 13–16.
- M. R. Mir, N. Jain, P. S. Jaget, W. Khan, P. K. Vishwakarma, D. K.
Rajak, B. A. Malik and
R. C. Maurya, Urinary tract anti-infectious potential of
DFT-experimental composite analyzed ruthenium nitrosyl complex of
N-dehydroaceticacid-thiosemicarbazide, Journal of King Saud
University-Science ,31 (2019) 89–100.
- J. M. Mir, N. Jain, P. S. Jaget and R. C. Maurya. Density
Functionalized [RuII(NO)(Salen)(Cl)] Complex:
computational,photodynamics and in vitro anticancer
facets,Photodiagnosis and Photodynamic Therapy , 19 (2017)
363-374.
- J. M. Mir, N. Jain, B. A. Malik, R. Chourasia, P. K. Vishwakarma.
Urinary tract infection fighting potential of newly synthesized
ruthenium carbonyl complex of N-dehydroacetic
acid-N′-o-vanillin-ethylenediamine, Inorg. Chim. Acta ,
467(2017) 80-92.
- J. M. Mir, R. C. Maurya, A new Ru(II) carbonyl complex of
2-benzoylpyridine: Medicinal and material evaluation at the
computational–experimental convergence. J. Chin. Adv.. Mater.
Soc. , 6 (2018) 156-168.
- J. M. Mir and R. C. Maurya, A gentle introduction to gasotransmitters
with special reference to nitric oxide: Biological and chemical
implications, Rev. Inorg. Chem .,38 (2018) 193–220.
- J. M. Mir, B. A. Malik, M. W. Khan and R. C. Maurya, Molybdenum
dinitrosyl Schiff base complexes of dehydroacetic acid and thiourea
derivatives: DFT-experimental characterization and nosocomial
anti-infectious implications, J. Chin. Chem. Soc., (2019)1–9;
DOI:10.1002/jccs.201800337.
- J. M. Mir and R. C. Maurya, Experimental and theoretical insights of a
novel molybdenum(0) nicotine complex containing CN and NO as
co-ligands, J. Chin. Adv.. Mater. Soc. ,
2018;doi.org/10.1080/22243682.2018.1534608.
- J. M. Mir, R. C. Maurya. Nitric oxide functionalized molybdenum (0)
pyrazolone Schiff base complexes: thermal and biochemical study, RSC
Adv., 8(2018) 35102–35130.
- J. M. Mir and R. C. Maurya, Physiological and pathophysiological
implications of hydrogen sulfide: A persuasion to change the fate of
the dangerous molecule, J. Chinese Adv. Mater.Soc ., 2018;
DOI:10.1080/22243682.2018.1493951.
- R. C. Maurya and J. M. Mir, A Gentle Introduction to Gasotransmitters,
NO, CO and H2S, Lap Lambert Academic Publishing,
Deutschland, Germany, ISBN: 978-3-330-01114-4 (2016) 1-309; R. C.
Mauryaand J. M. Mir, “NO-, CO-, and H2S-Based
Metallopharmaceuticals”, in “Advances in Metallodrugs: Preparation
and Applications in Medical Chemistry”, Shahid-ul-Islam,
AtharAdilHashmi and Salman Ahmad Khan (Eds.), Scrivener Publishing
LLC, Beverly, MA,ISBN: 978-1-119-64042-4(2020)157–202.A.
- A. K. Mustafa, M. M. Gadallaand S. H. Snyder. Signaling by
gasotransmitters, Sci. Signal , 2 (2009) 1-8.
doi:10.1126/scisignal.268re2.
- L. Li, P. Roseand P. K. Moore, Hydrogen sulfide and cell signaling,Annu. Rev. Pharmacol. Toxicol , 51(2011) 169–187.
- R. F. Furchgott and J. V. Zawadzki, The obligatory role of endothelial
cells in the relaxation of arterial smooth muscle by acetylcholine,Nature , 288 (1980) 373–376.
- A. Hermann, G. F. Sitdikova, T. M. Weiger (Eds.), Gasotransmitters:
Physiology and Pathophysiology, Springer-Verlag (2012).
- M. A. Marletta, Nitric oxide synthase structure and mechanism, J.
Biol. Chem., 268(1993) 12231-12234; C. F. Nathan, Nitric oxide as a
secretory product of mammalian cells, FASEB J 6(1992) 3051-3064.
- U.
Förstermannand H.
Kleinert, Nitric oxide synthase: Expression and expressional control
of the three isoforms, Naunyn-Schmiedeberg’s. Arch. Pharmacol .,
352 (1995) 351-364;R. G. Knowles, S. Moncada, Nitric oxide synthases
in mammals, Biochem. J ., 298 (1994) 249-258.
- F. Becquet, Y. Courtois, O. Goureau,Nitric oxide decreases in vitro
phagocytosis of photoreceptor outer segments by bovine retinal
pigmented epithelial cells, J. Cell. Physiol . 159(1994)
259-262.
- F. Becquet, Y. Courtois, and O. Goureau, Nitric Oxide in the eye:
Multifaceted roles and diverse outcomes, Surv. Ophthalmol , 42
(1997) 71-82.
- J. F. Kerwin, J. R. Lancaster and P. L. Feldman, Nitric oxide: a new
paradigm for second messengers, J. Med. Chem ., 38 (1995)
4343-4362.
- D. S. Bredt and S. H. Snyder, Nitric oxide: a physiologic messenger
molecule, Ann. Rev. Biochem ., 63(1994) 175-195; J. Koistinaho,
S. M. Sagar, NADPH diaphorase reactive neurones in the retina,Prog. Ret. Eye Res ., 15(1995) 69-87.
- C.
M. Venturini,
R.
G. Knowles,
R.
M. J. Palmer and
S.
Moncada, Synthesis of nitric oxide in the bovine retina,Biochem. Biophys . Res. Comm ., 180 (1991) 920-925.
- O.
Goureau, J.
Bellot, B.
Thillaye, Y.
Courtois and
Y.
de Kozak, Increased nitric oxide production in endotoxin-induced
uveitis: reduction of uveitis by an inhibitor of nitric oxide
synthase. J. Immunol ., 154 (1995) 6518-6523.
- A.
Yoshida,
N.
Pozdnyakov,
L.
Dang and
S.
M. Orselli, Nitric oxide synthesis in retinal photoreceptor cells,Visual Neuroscience , 12(1995) 493-500.
- N. N. Osborne. N. L. Barnett, A. J. Herrera, NADPH diaphorase
localization and nitric oxide synthetase activity in the retina and
anterior uvea of the rabbit eye, Brain Res ., 610 (1993)
194-198.
- R. Yamamoto, D. S. Bredt, S. H. Snyder and R. A. Stone, The
localization of nitric oxide synthase in the eye and related cranial
ganglia, Neurosci ., 54 (1993)189-200.
- K. Koch, H. Lambrecht, M. Haberecht,
D.
Redburn and
H.
H. Schmidt, Functional coupling of a
Ca2+/calmodulin dependent nitric oxide synthase and
a soluble guanyl cyclase in vertebrate photoreceptor cells, EMBO J,
13(1994) 3312-3320.
- M. T. R. Perez, B. Larsson, P. Aim, Localization of neuronal nitric
oxide synthase-immunoreactivity in rat and rabbit retinas, Brain Res.,
104(1995) 207-217.
- B. A. Lieppe, C. Stone, J. Koistinaho, D. R. Copenhagen, Nitric oxide
synthase in Müller cells and neurons of salamander and fish retina,J. Neurosci ., 14 (1994) 7641-7654.
- J. T. Rosenbaum, H. O. MacDevitt, R. B. Guss, P. R. Egbert,
Endotoxin-induced uveitis in rats as a model for human disease,Nature , 286 (1980) 611-613.
- N. N. Osborne, N. L. Barnett, A. J. Herrera, NADPH diaphorase
localization and nitric oxide synthetase activity in the retina and
anterior uvea of the rabbit eye, Brain Res ., 610 (1993)194-198.
- U. Chakravarthy, A. W. Stitt, J.
McNally,J.
R.
Bailie, E.
M. Hoeyand
P
Duprex, Nitric oxide synthase activity and expression in retinal
capillary endothelial cells and pericytes, Curr. Eye Res ., 14
(1995) 285-294.
- J. A. Nathanson, and McKee, Identification of an extensive system of
nitric oxide-producing cells in the ciliary muscle and outflow pathway
of the human eye, Invest . Ophthalmol . Vis .Sci. , 36 (1995)1765-1773.
- O. Goureau, D. Hicks, Y. Courtois and Y. de Kozak, Induction and
regulation of nitric oxide synthase in retinal Müller glial cells,J. Neurochem ., 63(1994)310-317.
- O. Goureau, M. Lepoivre and Y. Courtois, Lipopolysaccharide
andcytokines induce a macrophage-type of nitric oxide synthasein
bovine retinal pigmented epithelial cells.Biochem. Biophys. Res.
Comm ., 186 (1992) 854-859.
- O. Goureau, D. Hicks and Y. Courtois, Human retinal pigmented
epithelial cells produce nitric oxide in response to cytokines,Biochem. Biophys. Res. Comm ., 198 (1994) 120-126.
- J. Liversidge, P. Grabowski, S. Ralston, Rat retinal pigment
epithelial cells express an inducible form of nitric oxide synthase
and produce nitric oxide in response to inflammatory cytokines and
activated T cells, Immunology , 83 (1994) 404-409; J. R.
Sparrow, C. F. Nathan, Y. Vodovotz, Cytokine regulation of nitric
oxide synthase in mouse retinal pigment epithelial cells in culture,Exp. Eye Res ., 59(1004)129-139.
- C. L. Hartsfield, Cross talk between carbon monoxide and nitric oxide,Antioxid. Redox Signal , 4 (2002) 301–307.
- M. A. Gonzales and P. K. Mascharak, Photoactive metal carbonyl
complexes as potential agents for targeted CO delivery, J.
Inorg . Biochem ., 133 (2014) 127–135; T. R. Johnson, B. E.
Mann, J. E. Clark, R. F., Colin J. Green and R. Motterlini, Metal
carbonyls: a new class of pharmaceuticals ?, Angew. Chem. Int.
Ed. , 42 (2003) 3722-3729.
- M. D. Maine, The heme oxygenase system: A regulator of second
messenger gases, Annu. Rev. Pharmacol . Toxicol. ,
37(1997) 517-554.
- R. Tenhunen, H. S. Marver and R. Schmid, Microsomal heme oxygenase:
Characterization of the enzyme, J. Biol. Chem ., 1969, 244,
6388-6394.
- R. Schmid, A. F. McDonagh, ThePorphyrins, Vol. VI (Ed.: D. Dolphin),
Academic Press, New York (1979) 257-293.
- R. Motterlini, A. Gonzales, R. Foresti, J. E. Clark, C. J. Green and
R. M. Winslow, Heme oxygenase-1−derived carbon monoxide contributes to
the suppression of acute hypertensive responses in vivo,Circ.Res. , 83(1998) 568-577.
- T. R. Johnson, B. E. Mann, J. E. Clark, R. F., Colin J. Green and R.
Motterlini, Metal carbonyls: a new class of pharmaceuticals ?,Angew. Chem. Int. Ed. , 42(2003) 3722-3729.
- L. J. Ignarro, G. Cirino, A. Alessandro and C. Napoli,Nitric oxide as
a signalling molecule in the vascular system: an overview, J.
Cardiovasc. Pharmacol ., 34 (1999) 879-886.
- L. J. Ignarro, Nitric Oxide: Biology and Pathobiology, Academic Press,
San Diego, 2000.
- D. M. Lawson, C. E. M. Stevenson, C. R. Andrew and R. E. Eady,
Unprecedented proximal binding of nitric oxide to heme: implications
for guanylate cyclase, EMBO J ., 19 (2000) 5661-5671.
- J. R. Stone and M. A. Marletta, Soluble guanylate cyclase from bovine
lung: activation with nitric oxide and carbon monoxide and spectral
characterization of the ferrous and ferric states,Biochemistry ,
33(1994) 5636-5640.
- G. Deinum, J. R. Stone, G. T. Babcock and M. A. Marletta, Binding of
nitric oxide and carbon monoxide to soluble guanylate cyclase as
observed with Resonance Raman Spectroscopy, Biochemistry , 1996,
35, 1540-1547.
- E. Martin, K. Czarnecki, V. Jayaraman, F. Murad and J.
Kincaid,Resonance
Raman and Infrared Spectroscopic Studies of High-Output Forms of Human
Soluble Guanylyl Cyclase, J. Am. Chem. Soc ., 127 (2005)
4625-4631.
- M. A. Gonzales and P. K. Mascharak, Photoactive metal carbonyl
complexes as potential agents for targeted CO delivery, J.
Inorg. Biochem. , 133 (2014) 127–135.
- S. Ghatta, D. Nimmagadda, X. Xu and S.T. O’Rourke, Large-conductance,
calcium-activated potassium channels: structural and functional
implications,Pharmacol. Therapeut ., 110 (2006)103-116.
- W. Zhao, J. Zhang, Y. Lu and R. Wang, The vasorelaxant effect of
H2S as a novel endogenous gaseous KATPchannel opener, EMBO J, 20 (2001) 6008–6016.
- L. Li, P. Rose and P. K. Moore, Hydrogen sulfide and cell signaling,Ann. Rev. Pharmacol . Toxicol ., 51(2011) 169–187.
- R. Wang, Physiological implications of hydrogen sulfide: a whiff
exploration that blossomed, Physiol. Rev ., 92 (2012) 791–896.
- M. Ishigami, K. Hiraki, K. Umemura, Y. Ogasawara, K. Ishii and H.
Kimura, A source of hydrogen sulfide and a mechanism of its release in
the brain, Antioxidants& Redox Signaling , 11(2009) 205–214.
- N. Shibuya, M. Tanaka, M. Yoshida, Y. Ogasawara, T. Togawa, K. Ishii
and H. Kimura,3-Mercaptopyruvate sulfurtransferase produces hydrogen
sulfide and bound sulfanesulfur in the brain, Antioxidants & Redox
Signaling 11(2009) 703–714.
- Y. Mikami, N. Shibuya, Y. Kimura, N. Nagahara, Y. Ogasawara and H.
Kimura, Thioredoxin and dihydrolipoic acid are required for
3-mercaptopyruvate sulfurtransferaseto produce hydrogen
sulphide,Biochemical Journal , 439(2011) 479–485.
- C. Persa, K. Osmotherly, C. W. Chen, S. Moon, and M. F. Louabcd, The
distribution of cystathionine β-synthase (CBS) in the eye: Implication
of the presence of a trans-sulfuration pathway for oxidative stress
defense, Exp. Eye Res . 83(2006) 817–823
- W.
W
Pong, R.
Stouracova, N.
Frank, J.
P. Kraus and
W.
D. Eldred, Comparative localization of cystathionineβ-synthase and
cystathionineγ-lyase in retina: differences between amphibians and
mammals, J. Comp. Neurol ., 505 (2010) 158–165.
- Y. Mikami, N. Shibuya, Yuka Kimura, N. Nagahara, M. Yamada and H.
Kimura, Hydrogen sulfide protects the retina from light-induced
degeneration by the modulation of Ca2+influx,J. Biol. Chem ., 286 (2011) 39379-39386.
- N. Shibuya, S. Koike, M. Tanaka, M. Ishigami-Yuasa, Y. Kimura, Y.
Ogasawara, K. Fukui, N. Nagahara and H. Kimura, A novel pathway for
the production of hydrogen sulfide from
D-cysteine in mammalian cells, Nat. Commun , 4 (2013)1-7;DOI:
10.1038/ncomms2371
- M.
Kulkarni, Y.
F.
Njie-Mbye, I.
Okpobiri, M.
Zhao, C.
A.
Opere, S.
E. Ohia, Endogenous production of hydrogen sulfide in isolated bovine
eye, Neurochem. Res ., 36(2011) 1540–1545.
- J. D. Picker and H. L. Levy, Homocystinuria caused by cystathionine
beta-synthase deficiency, University of Washington, Seattle (2010).
- M.
Yu,
G.
Sturgill-Short,
P.
Ganapathy,
A.
Tawfik,
N.
S. Peachey, and
S.
B. Smith, Age-related changes in visual function in
cystathionine-beta- synthase mutant mice, a model of
hyperhomocysteinemia, Exp. Eye Res ., 96 (2012)124–131.
- P.
S. Ganapathy,
B.
Moister,
P.
Roon,
B.
A. Mysona,
J.
Duplantier,
Y.
Dun,
T.
K. V. E. Moister,
M.
J. Farley,
P.
D. Prasad,
K.
Liu and
S.
B. Smith, Endogenous elevation of homocysteine induces retinal neuron
death in the cystathionine-β-synthase mutant mouse, Invest.
Ophthalmol .Vis. Sci ., 50 (2009) 4460–4470.
- A.
Tawfik, S.
Markand , M.
Al-Shabrawey, J.
N.
Mayo, J.
Reynolds, S.
E.
Bearden, V.
Ganapathy
and S.
B. Smith, Alterations of retinal vasculature in
cystathionine-β-synthase heterozygous mice: a model of mild to
moderate hyperhomocysteinemia, Am. J. Pathol ., 184 (2014)
2573–2585.
- C. Bayse, ACS Symposium Series, American Chemical Society, Washington
DC, 2013.
- M. N. Hughes, N. M. Centellesand K. P. Moore, Making and working with
hydrogen sulfide: the chemistry and generation of hydrogen sulfidein vitro and its measurement in vivo : a review,Free Radic. Biol. Med ., 47(2009)1346–1353.
- M. C. Belardinelli, A. Chabli, B. Chadefaux-Vekemans and P. Kamoun,
Urinary sulphur compounds in Down syndrome, Clin. Chem., 47
(2001) 1500–1501.
- K. Fischer, J. Chen, M. Petri and J. Gmehling, Solubility of
H2S and CO2 in N-octyl-2-pyrrolidone
and of H2S in methanol and benzene, AIChE J ,
48(2002)887–893.
- E. A. Guenther, K. S. Johnson and K. H. Coale, Direct ultraviolet
spectrophotometric determination of total sulfide and iodide in
natural waters, Anal. Chem., 73 (2001)3481–3487.
- R. O. Beauchamp Jr., J. S. Bus, J. A. Popp, C. J. Boreiko and D. A.
Andjelkovich, A critical review of the literature on hydrogen sulfide
toxicity, Crit. Rev. Toxicol , 1964, 13,25–97.
- R. J. Reiffenstein, W. C. Hulbert, S. H. Roth. Toxicology of hydrogen
sulphide, Annu. Rev. Pharmacol. Toxicol , 32 (1992) 109–134.
- S. Kage, S. Kashimura, H. Ikeda, K. Kudo and N. Ikeda, Fatal and
nonfatal poisoning by hydrogen sulfide at an industrial waste site,J. Forensic Sci , 47 (2002) 652–655.
- G. C. Y. Chiou, Review: Effects of Nitric Oxide on Eye Diseases and
Their Treatment, J. Ocul. Pharmacol. Ther ., 17 (2001)189-198.
- M. Goldstein, P. Ostwald and S. Roth, Nitric Oxide: A Review of Its
Role in Retinal Function and Disease, Vision Res ., 36 (1996)
2979-2994.
- A.Yadav, R. Choudhary and S. H. Bodakhe, Role of Nitric Oxide in the
Development of Cataract Formation in CdCl2-induced
Hypertensive Animals, Current Eye Research . 43 (2018)
1454-1464.
- R. Balasubramanian, A. Bui, X. Dong, L. Gan, Lhx9 is required for the
development of retinal nitric oxide-synthesizing amacrine cell
subtype,Mol.Neurobiol ., 55 (2018) 2922–2933.
- Y. C. Tham, X. Li, T. Y. Wong, H. A. Quigley, T. Aung and C. Y. Cheng
CY, Global prevalence of glaucoma and projections of glaucoma burden
through 2040: A systematic review and meta-analysis,Ophthalmology , 121 (2014) 2081-90.
- H. A. Quigley and A. T. Broman, The number of people with glaucoma
worldwide in 2010 and 2020, Br. J. Ophthalmol ., 90 (2006)
262-267.
- L. K. Wareham, E. S. Buys and R. M. Sappington, The Nitric
Oxide-Guanylate Cyclase Pathway and Glaucoma, Nitric Oxide ,
77(2018) 75–87.
- M. S. Son, C. H. Park and J. W. Kim, Effect of Valproic Acid on Nitric
Oxide and Nitric Oxide Synthase in Trabecular Meshwork Cell, J.
Korean Ophthalmol. Soc ., 9 (2018) 543-548.
- M.
E.
Cavet , H.
H. DeCory,The Role of nitric oxide in the intraocular pressure
lowering efficacy of latanoprostenebunod: Review of nonclinical
studies, J. Ocul. Pharmacol. Ther .,34 (2017) 52-60.
- J. M. Mir and R. C. Maurya, NO news is good news for eyes: A mini
review, Ann. Ophthalmol. Vis. Sci ., 1(2018) 1003.
- J. A. Nathanson, Nitrovasodilators as a new class of ocular
hypotensive agents, J. Pharmacol . Exp. Ther ., 260 (1992)
956-965.
- H. Kotikoski, P. Alajuuma, E. Moilanen, P. Salmenperä, O. Oksala, P.
Laippala and H. Vapaatalo, Comparison of nitric oxide donors in
lowering intraocular pressure in rabbits: Role of cyclic GMP, J.
Ocul. Pharmacol. Ther ., 18 (2002)11-23.
- F. F. Behar-Cohen, O. Goureau, F. D′Hermies F, Y. Courtois and Y.
Courtois, Decreased intraocular pressure induced by nitric oxide
donors is correlated to nitrite production in the rabbit eye,Invest. Ophthalmol . Vis. Sci ., 37(1996)1711-1715.
- T. Sugiyama, T. Kida, K. Mizuno, S. Kojima and T. Ikeda, Involvement
of nitric oxide in the ocular hypotensive action of nipradilol,Curr. Eye Res ., 23(2001)346-351.
- M. Orihashi, Y. Shima, H. Tsuneki and I. Kimura, Potent reduction of
intraocular pressure by nipradilol plus latanoprost in ocular
hypertensive rabbits, Biol. Pharm. Bull ., 28 (2005) 65-68.
- J.Y. Hu, B. Katz, Non-arteritic ischemic optic neuropathy and
supplemental nitric oxide usage,Am.
J. Ophthalmol. Case Rep., 11 (2018) 26–27.
- A. Mahmud, M. Hennessy and J. Feely, Effect of sildenafil on blood
pressure and arterial wave reflection in treated hypertensive men.J. Hum. Hypertens ., 15 (2001)707-713.
- S. S. Hayreh, Erectile Dysfunction Drugs and Non-Arteritic Anterior
Ischemic Optic Neuropathy: Is There a Cause and Effect
Relationship?,J. Neuro-Ophthalmol ., 25(2005) 295–298.
- S. S. Hayreh, P. A. Podhajsky and B. Zimmerman, Non-arteritic anterior
ischemic optic neuropathy: time of onset of visual loss, Am. J.
Ophthalmol .,124(1997) 641-647.
- M. E. Cavet and H. H. DeCory, The Role of Nitric Oxide in the
Intraocular Pressure Lowering Efficacy of LatanoprosteneBunod: Review
of Nonclinical Studies, J. Ocul. Pharma. and Therap ., 34 (2018)
52-60.
- F. Galassi, E. Masini, B. Giambene, F. Fabrizi, C. Uliva, M. Bolla and
E Ongini, A topical nitric oxide-releasing dexamethasone derivative:
effects on intraocular pressure and ocular haemodynamics in a rabbit
glaucoma model, Br. J. Ophthalmol. , 90 (2006) 1414-1419.
- F. Impagnatiello, E. Bastia1, N. Almirante, S. Brambilla, B.
Duquesroix, A. C. Kothe and M. V. W. Bergamini,Prostaglandin analogues
and nitric oxide contribution in the treatment of ocular hypertension
and glaucoma, British Journal of Pharmacology , 176
(2019)1079–1089;
L. K. Wareham, E. S. Buys and R. M. Sappington, The Nitric
Oxide-Guanylate Cyclase Pathway and Glaucoma, Nitric Oxide,77(2018) 75-87;Q. Huang, E. Y. Rui, M. Cobbs, D. M. Dinh, H. J.
Gukasyan, J. A. Lafontaine, S. Mehta, B. D. Patterson, D. A.
Rewolinski, P. F. Richardson and M. P. Edwards, Design, synthesis, and
evaluation of NO-donor containing carbonic anhydrase inhibitors to
lower intraocular pressure, J. Med. Chem., 58 (2015) 2821–2833
- D. Sambhara and A. A. Aref, Glaucoma management: relative value and
place in therapy of available drug treatments, Ther. Adv.Chronic
Dis ., 5(2014)30–43.
- J. Harding, Cataract, Biochemistry, Epidemiology and
Pharmacology , Chapman & Hall, New York (1991).
- J. A. Bawer, B. P. Booth, and H. L. Fung, Nitric oxide donors:
Biochemical pharmacology and therapeutics , InNitric Oxide,
Biochemistry, Molecular Biology and Therapeutic Implications ,
Editors, L. Ignarro, and F. Murad, Academic Press, New York, pp.
361–381 (1995).
- R. Gaudana, H. K. Ananthula, A. Parenky and A. K. Mitra, Ocular Drug
Delivery, The AAPS Journal , 12 (2010) 348-360.
- C. Bucolo and F. Drago, Carbon monoxide and the eye: Implications for
glaucoma therapy,Pharmacology& Therapeutics 130 (2011) 191–201.
- V.
H. Lee and J.
R. Robinson,Topical Ocular Drug Delivery: Recent Developments and
Future Challenges, J. Ocul. Pharmacol ., 2 (1986) 67-108.
- S. Macha, A. K. Mitra, and P. M. Hughes, Overview of ocular drug
delivery, In A. K.Mitra (Ed.), Ophthalmic drug delivery systems (pp.
1−12), New York: MarcelDekker, Inc. (2003).
- A. Sommer, J. M. Tielsch, J. Katz, H. A.
Quigley,
J. D.
Gottsch,
J.
Javitt
and K.
Singh,
Relationship between intraocular pressure and primary open angle
glaucoma among white and black Americans: the Baltimore eye survey,Archives of Ophthalmology , 109 (1991)1090-1095.
- E. Stagni, M. G. Privitera, C. Bucolo, G. M. Leggio, R. Motterlini,
and F. Drago, A water-soluble carbon monoxide-releasing molecule
(CORM-3) lowers intraocular pressure in rabbits, British Journal
of Ophthalmology , 93 (2009) 254-257.
- X. Gasull, E. Ferrer, A. Llobet, A. Castellano, J. M. Nicolás, J.
Palés, and A. Gual, Cell membrane stretch modulates the
high-conductance Ca2+-activated K+channel in bovine trabecular meshwork cells, Invest. Ophthalmol.
Vis. Sci., 44 (2003)706-714.
- D. Wakefield, J. H. Chang, Epidemiology of uveitis, Int.
Ophthalmol. Clin . 45 (2005) 1–13.
- P. Fagone, K. Mangano, S. Mammana, E. Cavalli, R. D. Marco, M. L.
Barcellona, L. Salvatorelli, G. Magro, F. Nicoletti, Carbon
monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of
experimental autoimmune uveoretinitis (EAU) in rats, Clinical
Immunology ,157(2015) 198–204
- C. Szabo, Hydrogen sulphide and its therapeutic potential, Nat. Rev.
Drug Discov., 6 (2007) 917–935.
- F. Maggio, Glaucomas, Top. Companion Anim. Med . 30 (2015)
86–96.
- A. V. Mantravadi and N. Vadhar, Glaucoma, Prim. Care Clin. Off.
Pract ., 42 (2015)
- H. Neufeld, D. K. Dueker, T. Vegge and M. L. Sears, Adenosine 3′,
5′-monophosphateincreases the outflow of aqueous humour from the
rabbit eye, Invest. Ophthalmol ., 14 (1975) 40-42.
- J.
Robinson, E.
Okoro, C.
Ezuedu , L.
Bush , C.
A.
Opere, S.
E.
Ohia, Y.
F. Njie-Mbye, Effects of hydrogen sulfide-releasing compounds on
aqueous humor outflow facility in porcine ocular anterior segments, ex
vivo, J. Ocul. Pharmacol ., 33(2017) 91-97.
- K.
Módis,
P.
Panopoulos,G. Olah,C. ColettaA. Papapetropoulos and
C.
Szabo, Role of phosphodiesterase inhibition and modulation of
mitochondrial cAMP levels in the bioenergetic effect of hydrogen
sulfide in isolated mitochondria. Nitric oxide, 31(2013) S28.
- E. Perrino, C. Uliva, C. Lanzi, P. D. Soldato, E. Masini and A.
Sparatore, New prostaglandin derivative for glaucoma treatment,Bioorg. Med. Chem. Lett ., 19 (2009)1639–1642.
- A. Salvi, P. Bankhele, J. Jamil, M. KulkarniChitnis, Y. F. Njie-Mbye,
S. E. Ohia and C. A. Opere, Effect of hydrogen sulfide donors on
intraocular pressure in rabbits. J. OcularPharmacol.
Therapeut ., 32 (2016) 371–375.